Taiwanese Journal of Obstetrics & Gynecology (May 2022)

Rare live birth to a 48-year-old woman after embryo transfer with autologous oocyte: A case report

  • Te-Wei Wu,
  • Horng-Der Tsai,
  • Hsiao-Chin Huang,
  • Hsaio-Hsuan Yang,
  • Yu-Jing Chen,
  • Hsin-Hung Wu,
  • Chen-Hsuan Wu

Journal volume & issue
Vol. 61, no. 3
pp. 551 – 554

Abstract

Read online

Objective: Advanced maternal age and decreased ovarian reserve have been challenges for assisted reproductive technology (ART). Few cases, using autologous oocytes more than 46-years-old, have previously been reported. We seek to show how the age at which autologous oocytes may successfully be employed may be increasing. Case report: We report a 47-year-old woman with an anti-Müllerian hormone (AMH) level of 0.24 ng/mL, conceived through in vitro fertilization (IVF) using autologous oocytes. Patient was given an antagonist protocol for ovarian stimulation and one frozen-thawed embryo was transferred. The patient became pregnant. The course of her pregnancy was uneventful and she gave birth to a 3330 gm male baby by cesarean section. Conclusion: Technological advances permit women, who previously would have been considered too old to employ an autologous oocyte, to have a successful pregnancy with a live birth.

Keywords